← Research & News
industry 📅 May 16, 2026 7 min read

Exemestane / Aromasin — New Aromatase Inactivator Research Profile Added

Comprehensive research profile for exemestane (Aromasin): mechanism of irreversible CYP19A1 inactivation, suicide inhibition, no estrogen rebound, bloodwork monitoring (E2, bone markers, lipids), PCT advantage, and harm reduction.

🔬 All compounds discussed on this site are for research use only (RUO). This article is provided for educational purposes and does not constitute medical, legal, or regulatory advice.

← Back to Research & News